P
This company develops WoundCue™, a nanofiber membrane designed for visual, point-of-care detection of rising wound infection risk. The membrane reactively changes color based on critical thresholds of bacterial or fungal presence, signaling the need for proactive clinical intervention. This technology provides continuous monitoring without requiring culturing, devices, or connectivity, supporting earlier treatment decisions in diverse care settings.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops WoundCue™, a nanofiber membrane designed for visual, point-of-care detection of rising wound infection risk. The membrane reactively changes color based on critical thresholds of bacterial or fungal presence, signaling the need for proactive clinical intervention. This technology provides continuous monitoring without requiring culturing, devices, or connectivity, supporting earlier treatment decisions in diverse care settings.